familial dysalbuminemic hyperthyroxinemia
MeSH: D050010ORPHA: 2762711 Treatment Available
Overview
medical condition
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| levothyroxine sodium | oral tablet, 25-300mcg | FDA Approved | 11 | 3d |
Classification & Codes
MeSH Code
D050010Orphanet Code
ORPHA:276271familial dysalbuminemic hyperthyroxinemia
| MeSH | D050010 |
| Orphanet | ORPHA:276271 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO